XOMA Ltd. (XOMA) Stock News, Earnings & History

(NASDAQ:XOMA) Healthcare

Enjoy Interactive Tools and Indicators

52wk high: 4.40
52wk low: 2.37
EPS: -0.88
P/E: N/A
Div Rate: N/A
Yield: N/A
Market Cap: 319.14M
Avg Vol (3m): 660,109

Latest Headlines

More Articles About XOMA →

Company On Twitter

Company Profile

XOMA Ltd., a biopharmaceutical company, develops and manufactures genetically engineered protein, peptide, and antibody pharmaceuticals. The Company's medical targets include bacterial and fungal infections, infectious complications, and immunologic and inflammatory disorders. XOMA's primary drug development platform is bactericidal/permeability-increasing protein.


Investor Relations | Press Releases

Insider Trading Cheat Sheet

No insider trading data available for XOMA Ltd..

Yahoo, HV, Market Watch, The Wall St. Journal